Literature DB >> 19906781

Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway.

Rosario Jiménez1, Manuel Sánchez, María José Zarzuelo, Miguel Romero, Ana María Quintela, Rocío López-Sepúlveda, Pilar Galindo, Manuel Gómez-Guzmán, Jose Manuel Haro, Antonio Zarzuelo, Francisco Pérez-Vizcaíno, Juan Duarte.   

Abstract

Peroxisome proliferator-activated receptor beta/delta (PPAR-beta) is a ligand-activated transcription factor belonging to the nuclear hormone receptor superfamily that regulates the transcription of many target genes. More recently, acute, nongenomic effects of PPAR-beta agonists have also been described. In the present study, we hypothesized that PPAR-beta agonists might exert acute nongenomic effects on vascular tone. Here, we report that the structurally unrelated PPAR-beta ligands [4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy]acetic acid (L-165041) and 4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl] methyl]thio]-2-methylphenoxy]acetic acid (GW0742) induced vascular relaxation in phenylephrine-precontracted endothelium-intact rat aortic rings, which was significantly inhibited by endothelial denudation or nitric-oxide synthase (NOS) inhibition with N(G)-nitro-l-arginine methylester. These relaxant effects reached steady state within 15 min. The relaxation induced by L-165041 and GW0742 in aortic rings precontracted with the thromboxane A(2) analog 9,11-dideoxy-11alpha,9alpha-epoxymethanoprostaglandin F2alpha (U-46619) was unaffected either by removal of extracellular calcium or by incubation with calcium-free solution containing the intracellular calcium chelator 1,2-bis-(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetra(acetoxymethyl) ester. However, the phosphatidylinositol 3-kinase (PI3K) inhibitor 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY-294002) inhibited the endothelium-dependent relaxant responses induced by both PPAR-beta agonists. Blockade of PPAR-beta with 3-[[[2-methoxy-4-(phenylamino)phenyl]amino]sulfonyl]-2-thiophenecarboxylic acid methyl ester (GSK0660) also partially inhibited these relaxant responses, although PPAR-gamma blockade with 2-chloro-5-nitro-N-phenylbenzamide (GW9662) had no effect. In human umbilical vein endothelial cells, L-165041 and GW0742 increased nitric oxide (NO) production and Akt and endothelial NOS (eNOS) phosphorylation, which were sensitive to PI3K inhibition and PPAR-beta blockade. In conclusion, the PPAR-beta agonists acutely caused vasodilatation, which was partially dependent on endothelial-derived NO. The eNOS activation is calcium-independent and seems to be related to activation of the PI3K-Akt-eNOS pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906781     DOI: 10.1124/jpet.109.159806

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.402


  15 in total

1.  Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome.

Authors:  Rebecca Lee Yean Wong; Cheryl Lyn Walker
Journal:  Clin Cancer Res       Date:  2013-04-02       Impact factor: 12.531

2.  3',4'-Dimethoxythioflavone induces endothelium-dependent vasorelaxation through activation of epidermal growth factor receptor.

Authors:  Eun Jin Jang; Young Mi Seok; Jae In Lee; Hyun Min Cho; Uy Dong Sohn; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-12       Impact factor: 3.000

Review 3.  The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.

Authors:  Wai San Cheang; Xiao Yu Tian; Wing Tak Wong; Yu Huang
Journal:  Br J Pharmacol       Date:  2015-01-23       Impact factor: 8.739

Review 4.  Selenium and selenoproteins in prostanoid metabolism and immunity.

Authors:  Fenghua Qian; Sougat Misra; K Sandeep Prabhu
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-01-30       Impact factor: 8.250

5.  PPARβ activation restores the high glucose-induced impairment of insulin signalling in endothelial cells.

Authors:  A M Quintela; R Jiménez; L Piqueras; M Gómez-Guzmán; J Haro; M J Zarzuelo; A Cogolludo; M J Sanz; M Toral; M Romero; F Pérez-Vizcaíno; J Duarte
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

6.  Antiplatelet activity of nifedipine is mediated by inhibition of NF-κB activation caused by enhancement of PPAR-β/-γ activity.

Authors:  Ching-Yu Shih; I-Hsin Lin; James-Cheng Ding; Fu-Chi Chen; Tz-Chong Chou
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

7.  Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-δ activation.

Authors:  Li Li; Zhidan Luo; Hao Yu; Xiaoli Feng; Peijian Wang; Jian Chen; Yunfei Pu; Yu Zhao; Hongbo He; Jian Zhong; Daoyan Liu; Zhiming Zhu
Journal:  Diabetes       Date:  2012-12-13       Impact factor: 9.461

8.  PPARδ activation protects endothelial function in diabetic mice.

Authors:  Xiao Yu Tian; Wing Tak Wong; Nanping Wang; Ye Lu; Wai San Cheang; Jian Liu; Limei Liu; Yahan Liu; Susanna Sau-Tuen Lee; Zhen Yu Chen; John P Cooke; Xiaoqiang Yao; Yu Huang
Journal:  Diabetes       Date:  2012-08-28       Impact factor: 9.461

9.  Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS.

Authors:  Zhigang Zhao; Zhidan Luo; Peijian Wang; Jing Sun; Hao Yu; Tingbing Cao; Yinxing Ni; Jing Chen; Zhencheng Yan; Daoyan Liu; Zhiming Zhu
Journal:  PPAR Res       Date:  2011-11-22       Impact factor: 4.964

10.  PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists.

Authors:  Neerupma Silswal; Nikhil K Parelkar; Michael J Wacker; Mostafa Badr; Jon Andresen
Journal:  PPAR Res       Date:  2012-09-11       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.